Arcturus Therapeutics Holdings Inc. (ARCT)

ARCT Revenue

Arcturus Therapeutics Holdings had revenue of $2.06M in the quarter ending March 31, 2026, a decrease of -92.99%. This brings the company's revenue in the last twelve months to $54.71M, down -61.92% year-over-year. In the year 2025, Arcturus Therapeutics Holdings had annual revenue of $82.03M, down -46.14%.

• Revenue (ttm): $54.71M
• Revenue Growth: -61.92%
• P/S Ratio: 4.07
• Revenue / Employee: $492,883
• Employees: 111
• Market Cap: 222.55M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	82.03M	-70.28M	-46.14%
Dec 31, 2024	152.31M	-14.49M	-8.69%
Dec 31, 2023	166.80M	-39.20M	-19.03%
Dec 31, 2022	206.00M	193.64M	1,566.79%
Dec 31, 2021	12.36M	2.82M	29.56%
Dec 31, 2020	9.54M	-11.25M	-54.12%
Dec 31, 2019	20.79M	5.04M	31.97%
Dec 31, 2018	15.75M	2.76M	21.20%
Dec 31, 2017	13.00M	-7.38M	-36.23%
Dec 31, 2016	20.38M	14.24M	232.06%
Dec 31, 2015	6.14M	-	-
Dec 31, 2014	-	-	-
Dec 31, 2013	-	-	-
Dec 31, 2012	-	-	-
Dec 31, 2011	-	-	-

Data Source: Fiscal.ai Last updated: May 7, 2026

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 14, 2026

Data Sources Report a data error